Omacor NDA Approved

The US FDA has approved a new drug application submitted by Ross Products Division of Abbott Laboratories for Omacor (omega-3-acid ethyl esters) Capsules as an adjunct to diet to reduce triglyceride levels in adult patients with triglyceride levels > 500mg/dL. The product description notes that the product is a combination of ethyl esters of eicosapentanoic acid (EPA - approximately 465 mg) and docosahexanoic acid (DHA - approximately 375 mg).

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.